Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

Merit Medical Systems (MMSI) EBIAT (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed EBIAT for 16 consecutive years, with $38.0 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 35.99% to $38.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $128.5 million through Dec 2025, up 6.76% year-over-year, with the annual reading at $128.5 million for FY2025, 6.76% up from the prior year.
  • EBIAT hit $38.0 million in Q4 2025 for Merit Medical Systems, up from $27.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $38.0 million in Q4 2025 to a low of $4.9 million in Q2 2021.
  • Historically, EBIAT has averaged $23.3 million across 5 years, with a median of $26.7 million in 2023.
  • Biggest YoY gain for EBIAT was 501.04% in 2021; the steepest drop was 56.69% in 2021.
  • Year by year, EBIAT stood at $20.6 million in 2021, then skyrocketed by 62.04% to $33.4 million in 2022, then dropped by 17.28% to $27.6 million in 2023, then grew by 1.15% to $27.9 million in 2024, then surged by 35.99% to $38.0 million in 2025.
  • Business Quant data shows EBIAT for MMSI at $38.0 million in Q4 2025, $27.8 million in Q3 2025, and $32.6 million in Q2 2025.